Rajiv Mahajan

492 posts

Rajiv Mahajan banner
Rajiv Mahajan

Rajiv Mahajan

@Rajiv_EP

Clinical Lead for Electrophysiology and Pacing, Lyell McEwin Hospital | A/Prof at University of Adelaide

Adelaide, South Australia 가입일 Haziran 2013
362 팔로잉1.9K 팔로워
Rajiv Mahajan 리트윗함
JACC Journals
JACC Journals@JACCJournals·
#WhyCMR by LGE in sarcoidosis, new precision in prognosis? Large #UK cohort of biopsy-proven cardiac sarcoidosis finds that LGE extent was an independent predictor of VAs or device therapy. #JACCIMG offers a novel approach to arrhythmic risk stratification jacc.org/doi/10.1016/j.…
JACC Journals tweet mediaJACC Journals tweet media
English
0
25
79
13.1K
Rajiv Mahajan 리트윗함
Heart Rhythm Society
Heart Rhythm Society@HRSonline·
What defines an AFib Center of Excellence? HRS lays it out in a new consensus statement: “Criteria for the Establishment of Atrial Fibrillation Centers of Excellence.” Chaired by Drs. @TJaredBunch and @deering_f, this multidisciplinary effort offers a checklist of criteria that care teams can strive for to elevate their AFib care. Read the full paper: bit.ly/42Ejf8O #AFib #EPeeps #HRS2025
Heart Rhythm Society tweet media
English
0
6
9
1.7K
Rajiv Mahajan 리트윗함
Mintu Turakhia, MD MS
Mintu Turakhia, MD MS@leftbundle·
The long-term incidence of stroke in AF is low, especially after ablation of paroxysmals. Stroke scores are from another era and were not developed or validated in this population: CHADSVASC was derived from 20-year old data with ONE YEAR of follow-up. The treatment effect of statins, BP control, and reduced risk of HF may be contributing more to fewer strokes in AF. Recent AF screening trials have all shown stroke event rates lower than historical. We need a clever and cautious way to redefine risk stroke in contemporary AF patients before assuming that the historical reduction is all from therapy. #AHA24
Prof Dhiraj Gupta@DhirajGuptaBHRS

This is another huge takeaway from the OPTION trial: how low the incidence of stroke is post modern AF ablation. The CHADSVA tool is meaningless in this cohort, where AF burden has been substantially reduced with ablation

English
7
17
96
18.2K
Rajiv Mahajan 리트윗함
Jason Andrade
Jason Andrade@DrJasonAndrade·
Congratulations to @RivardLena on the @AHAScience presentation of the BRAIN-AF study results. Major observation is that cognitive decline occurs in many « low risk » AF patients. Unfortunately, Rivaroxaban 15 mg daily did not impact this risk in this double-dummy RCT.
Jason Andrade tweet mediaJason Andrade tweet mediaJason Andrade tweet mediaJason Andrade tweet media
English
3
16
54
3.6K
Rajiv Mahajan 리트윗함
APHRS2024
APHRS2024@aphrs2024·
#APHRS2024 - LBCT Session 🗓️29/09 at 1:30pm 📍C3.4 | C3.5 Get ready for one of the most anticipated session of the event – Late-Breaking Clinical Trials! 🚨📊 Join us as leading experts reveal the latest groundbreaking studies that are set to transform patient care and medical practice. Whether you're a clinician, researcher, or healthcare professional, this session will offer invaluable insights into cutting-edge innovations and clinical breakthroughs. #MedicalBreakthroughs #HealthcareInnovation #CardioTwitter #ResearchInMedicine
APHRS2024 tweet media
English
0
5
11
3K
Rajiv Mahajan 리트윗함
Jason Andrade
Jason Andrade@DrJasonAndrade·
We looked at this is AFFIRM & AF-CHF almost 10 years ago HR affects prognosis differently in AF vs sinus. In sinus more related to mortality. In af more related to hospitalisation In AF - lower HR wasn’t better. heartrhythmjournal.com/article/S1547-…
Jason Andrade tweet mediaJason Andrade tweet mediaJason Andrade tweet mediaJason Andrade tweet media
JACC Journals@JACCJournals

Heart rate (HR) control of ≤80 beats/min in pts w/ HF & #AFib leads to better clinical outcomes after discharge. Prospective, large-scale, RCTs are needed to determine if HR management improves long-term outcomes. bit.ly/3Mwuasu #JACCAdvances #HeartFailure #CardioX

English
3
8
33
6.6K
Rajiv Mahajan 리트윗함
Roderick Tung
Roderick Tung@DrRoderickTung·
Insta-termination with 1st epi RF over incomplete endo anterior line at Bachmann/VOM junction. A fully percutaneous catheter-based MAZE is within reach. #AFin3D
English
6
45
191
15.1K